Lannett Receives Approval For Hydrocodone Bitartrate and Acetaminophen Tablets USP, 5 mg/300 mg, 7.5 mg/300 mg And 10 mg/300 mg

PHILADELPHIA, June 22, 2017 -- (Healthcare Sales & Marketing Network) -- Lannett Company, Inc. (NYSE: LCI) today announced that it received approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA) for Hydroc... Biopharmaceuticals, Generics, FDA Lannett, Hydrocodone, Acetaminophen, Vicodin
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news